Optimizing Translation: In-Country Review in Life Sciences
Part 1: Eliminating ICR in the Translation Process
In-country review (ICR) is commonly seen as a bottleneck, adding time and cost to the translation process. The result is often questionable, as reviewers may make unnecessary changes and introduce inconsistencies.
This guide, developed specifically for medical device and pharmaceutical organizations, focuses on the factors that influence translation quality and the possibility of eliminating ICR from the translation process.
